Liermann D, Strecker E P, Peters J
Department of Radiology, Klinikum der J.W. Goethe Universität Frankfurt, Germany.
Cardiovasc Intervent Radiol. 1992 Sep-Oct;15(5):298-305. doi: 10.1007/BF02733954.
We have implanted more than 100 Strecker stents in the iliac and femoral arteries. In iliac arteries, follow-up is available from 8 to 48 months (mean 20 months) and in peripheral arteries, from 8 to 32 months (mean 19 months). In iliac and proximal femoral arteries there was a patency rate of 98% (mean 20 months after stent implantation) whereas in peripheral arteries the patency rate was 70.8% (mean 19 months after stent implantation). Besides careful selection of patients, anticoagulation is very important for successful stenting. Because of the excellent results of stents in iliac vessels there is a wide range of good indications, including primary stenting after recanalization of occlusions. In contrast, stent implantation in peripheral vessels should be restricted to special cases such as acute dissection or reocclusion after successful recanalization.
我们已在髂动脉和股动脉植入了100多个施特雷克支架。在髂动脉,随访时间为8至48个月(平均20个月),在外周动脉,随访时间为8至32个月(平均19个月)。在髂动脉和股动脉近端,支架植入后平均20个月的通畅率为98%,而在外周动脉,支架植入后平均19个月的通畅率为70.8%。除了仔细挑选患者外,抗凝对于支架植入成功非常重要。由于支架在髂血管中的效果极佳,有广泛的良好适应证,包括闭塞再通后的初次支架植入。相比之下,外周血管的支架植入应限于特殊情况,如急性夹层或成功再通后的再闭塞。